Stayble Therapeutics appoints new CFO
Stayble Therapeutics AB announces that Erik Kullgren has been appointed as the new CFO, effective August 1, 2024.Erik Kullgren has an MBA from the School of Economics at the University of Gothenburg and has extensive experience as a CFO for both listed and unlisted companies. He has also been CEO of Reguity Group AB and Dunross & Co AB. Erik Kullgren currently runs his own consulting company where he acts as CFO for, among others, Alzinova AB and Shortcut Media Group. We welcome Erik as the new CFO of Stayble and look forward to working together. With his solid experience and